00531nas a2200181   4500000000100000008004100001100001400042700001600056700001300072700001300085700001700098700001300115700001400128700001100142700001300153700001100166245017200177       2019                            d1 aCooper M.1 aWilliams B.1 aHamet P.1 aMarre M.1 aJuraschek S.1 aHarrap S1 aSelvin E.1 aWang D1 aMcEvoy J1 aLazo M00aResponse of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial